Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#81 / 200 Total
CVGI - Commercial Vehicle Group Inc - Stock Price Chart
TickerCVGI [NASD, RUT]
CompanyCommercial Vehicle Group Inc
CountryUSA
IndustryAuto Parts
Market Cap41.22MEPS (ttm)-1.05
P/E-EPS this Y-333.33%
Forward P/E7.00EPS next Y230.77%
PEG-EPS past 5Y-
P/S0.06EPS next 5Y-
P/B0.27EPS Q/Q-245.45%
Dividend-Sales Q/Q-26.83%
Insider Own15.02%Inst Own65.40%
Insider Trans0.87%Inst Trans-6.74%
Short Float4.82%EarningsMay 07/b
Analyst Recom1.00Target Price4.00
Avg Volume425.87K52W Range0.81 - 5.88
Commercial Vehicle Group, Inc. engages in the manufacture, supply, and sale of cab related products and systems. It operates through Vehicle Solutions, Electrical Systems, Aftermarket & Accessories, and Industrial Automation segments. The Vehicle Solutions segment designs, manufactures and sells heavy duty trucks, medium duty trucks, last mile delivery trucks and vans. The Electrical Systems segment engages in the designing, manufacturing and selling cable and harness assemblies for both high and low voltage applications, control boxes, dashboard assemblies and design and engineering for these applications. The Aftermarket & Accessories segment focuses on the designing, manufacturing and selling seats and components sold into the commercial vehicle channels that provide repair and refurbishing. The Industrial Automation segment designs, manufactures and sells warehouse automation subsystems including control panels, electro-mechanical assemblies, cable assemblies, and power and communication solutions. The company was founded in August 2000 and is headquartered in New Albany, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nauman J MichaelDirectorDec 03 '24Buy2.4219,36246,85682,997Dec 04 04:26 PM
Nauman J MichaelDirectorDec 04 '24Buy2.372,8386,72685,835Dec 04 04:26 PM
Nauman J MichaelDirectorDec 02 '24Buy2.402,8006,72063,635Dec 04 04:26 PM
RANCOURT WAYNE MDirectorNov 08 '24Buy2.5815,00038,700157,783Nov 12 04:59 PM
Nauman J MichaelDirectorNov 08 '24Buy2.5010025060,835Nov 12 04:19 PM
XPER - Xperi Inc - Stock Price Chart
TickerXPER [NYSE, RUT]
CompanyXperi Inc
CountryUSA
IndustrySoftware - Application
Market Cap365.06MEPS (ttm)-0.43
P/E-EPS this Y1.31%
Forward P/E5.79EPS next Y40.94%
PEG-EPS past 5Y-
P/S0.75EPS next 5Y-
P/B0.83EPS Q/Q-39.19%
Dividend-Sales Q/Q-4.05%
Insider Own5.13%Inst Own86.68%
Insider Trans0.00%Inst Trans-0.21%
Short Float2.98%EarningsMay 07/a
Analyst Recom1.25Target Price18.25
Avg Volume363.94K52W Range6.29 - 11.08
Xperi, Inc. is an entertainment technology company, which engages in the provision of services to streaming media platforms across smart television and video over broadband for operators and connected cars. It operates under the brands DTS, HD Radio, Imax Enhanced, and TiVo. The company was founded in December 2019 and is headquartered in San Jose, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIRCHNER JONCEO & PresidentSep 11 '24Buy8.655,00043,242523,692Sep 12 08:07 PM
Andersen Robert JChief Financial OfficerAug 30 '24Buy8.751,70014,875254,098Sep 03 07:11 PM
Marquez RebeccaCLO and SecretaryAug 23 '24Buy8.621,1509,913156,131Aug 27 04:38 PM
Habiger David CDirectorAug 22 '24Buy8.605,77549,68573,980Aug 26 07:47 PM
Antonellis DarcyDirectorAug 22 '24Buy8.5510,50089,77570,471Aug 26 05:36 PM
MRKR - Marker Therapeutics Inc - Stock Price Chart
TickerMRKR [NASD]
CompanyMarker Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap14.48MEPS (ttm)-1.20
P/E-EPS this Y-132.77%
Forward P/E-EPS next Y-6.68%
PEG-EPS past 5Y23.96%
P/S2.20EPS next 5Y-4.81%
P/B0.74EPS Q/Q-36.96%
Dividend-Sales Q/Q113.13%
Insider Own30.21%Inst Own25.40%
Insider Trans19.82%Inst Trans2.45%
Short Float2.50%EarningsMar 31/b
Analyst Recom1.00Target Price8.17
Avg Volume116.57K52W Range0.95 - 5.99
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ELMS STEVEDirectorDec 23 '24Buy3.2011,08535,472325,370Dec 26 04:01 PM
New Enterprise Associates 16, 10% OwnerDec 23 '24Buy3.20554,2501,773,6001,625,678Dec 23 04:40 PM
ACTG - Acacia Research Corp - Stock Price Chart
TickerACTG [NASD, RUT]
CompanyAcacia Research Corp
CountryUSA
IndustryBusiness Equipment & Supplies
Market Cap340.14MEPS (ttm)-0.36
P/E-EPS this Y-21.43%
Forward P/E-EPS next Y-245.45%
PEG-EPS past 5Y1.92%
P/S1.53EPS next 5Y-
P/B0.50EPS Q/Q13410.53%
Dividend-Sales Q/Q411.60%
Insider Own1.59%Inst Own86.20%
Insider Trans-0.97%Inst Trans-2.15%
Short Float1.57%EarningsMay 08/b
Analyst Recom1.00Target Price6.00
Avg Volume283.85K52W Range2.70 - 5.74
Acacia Research Corp. focuses on acquiring and operating businesses across the industrial, energy, and mature technology sectors where it believes it can leverage its expertise, significant capital base, and deep industry relationships to drive value. It operates through the following business segments: Intellectual Property Operations, Industrial Operations and Energy Operations. The Intellectual Property Operations segment invests in IP and related absolute return assets and engages in the licensing and enforcement of patented technologies. The Industrial Operations segment generates operating income by designing and manufacturing printers and consumable products for various industrial printing applications. The Energy Operations segment engages in the acquisition, exploration, development, and production of oil and natural gas resources located in Roberts and Hemphill Counties in Texas. The company was founded by Robert Bruce Stewart on January 25, 1993 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kohlberg Isaac T.DirectorNov 25 '24Sale4.5715,00068,57269,274Nov 26 04:01 PM
Kohlberg Isaac T.DirectorNov 25 '24Proposed Sale4.5715,00068,571Nov 25 04:09 PM
Soncini Jason W.General CounselMay 17 '24Buy5.365,00026,800226,661May 20 12:15 PM
McNulty Martin D. Jr.Chief Executive OfficerMay 16 '24Buy5.2514,53476,304193,699May 20 12:14 PM
McNulty Martin D. Jr.Chief Executive OfficerMay 17 '24Buy5.424,42824,000198,127May 20 12:14 PM
VSTS - Vestis Corp - Stock Price Chart
TickerVSTS [NYSE]
CompanyVestis Corp
CountryUSA
IndustryRental & Leasing Services
Market Cap826.28MEPS (ttm)-0.18
P/E-EPS this Y-50.60%
Forward P/E14.96EPS next Y36.83%
PEG-EPS past 5Y-34.27%
P/S0.30EPS next 5Y6.94%
P/B0.94EPS Q/Q-567.26%
Dividend1.46%Sales Q/Q-5.69%
Insider Own1.00%Inst Own98.75%
Insider Trans0.00%Inst Trans14.51%
Short Float5.71%EarningsMay 06/a
Analyst Recom2.78Target Price7.41
Avg Volume2.54M52W Range5.20 - 17.83
Vestis Corp. engages in the B2B uniform, and workplace supplies category. It operates through the United States and Canada geographical segments. It provides uniform services, and workplace supplies to North American customers from Fortune 500 companies to locally owned small businesses across a broad set of end markets. The company comprehensive service offering includes a full-service uniform rental program, cleanroom and other specialty garment processing, floor mats, towels, linens, managed restroom services, and first aid supplies. The company was founded in 2023 and is headquartered in Roswell, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pertz Douglas ADirectorMay 24 '24Buy11.9954,468653,055195,604May 29 05:47 PM
Pertz Douglas ADirectorMay 28 '24Buy11.6222,442260,706218,046May 29 05:47 PM
Shih GrantEVP and CTOMay 24 '24Buy12.008009,6006,187May 28 05:06 PM
Corvex Management LP10% OwnerMay 24 '24Buy12.02100,0001,202,00017,007,877May 24 06:34 PM
Corvex Management LP10% OwnerMay 23 '24Buy12.17100,0001,217,00016,907,877May 23 06:43 PM
CCRD - CoreCard Corporation - Stock Price Chart
TickerCCRD [NYSE]
CompanyCoreCard Corporation
CountryUSA
IndustrySoftware - Application
Market Cap155.81MEPS (ttm)0.68
P/E29.61EPS this Y16.46%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-11.37%
P/S2.71EPS next 5Y-
P/B3.01EPS Q/Q313.99%
Dividend-Sales Q/Q21.93%
Insider Own28.04%Inst Own41.58%
Insider Trans0.00%Inst Trans24.35%
Short Float1.08%EarningsMay 08/b
Analyst Recom3.00Target Price21.00
Avg Volume20.34K52W Range11.57 - 24.97
CoreCard Corp. engages in the management of emerging technology companies. It operates through CoreCard Software, Inc. and affiliate companies, which are involved in the design, development, and marketing of software solutions to corporations, financial institutions, retailers, and processors to manage credit and debit cards, prepaid cards, private label cards, fleet cards, loyalty programs, and accounts receivable and small loan transactions. The company was founded in 1973 and is headquartered in Norcross, GA.
RDVT - Red Violet Inc - Stock Price Chart
TickerRDVT [NASD, RUT]
CompanyRed Violet Inc
CountryUSA
IndustrySoftware - Application
Market Cap650.62MEPS (ttm)0.61
P/E77.03EPS this Y29.85%
Forward P/E39.58EPS next Y10.61%
PEG-EPS past 5Y-
P/S8.17EPS next 5Y-
P/B7.08EPS Q/Q88.41%
Dividend-Sales Q/Q25.65%
Insider Own21.71%Inst Own59.69%
Insider Trans-2.39%Inst Trans0.73%
Short Float6.87%EarningsMay 07/a
Analyst Recom1.00Target Price52.00
Avg Volume99.38K52W Range17.50 - 43.44
Red Violet, Inc. engages in the provision of software and proprietary technology services. It specializes in data and analysis sector, which provides cloud-based, mission-critical information solutions to enterprises in a variety of industries. Its brands include IDI and Forewarn. The company was founded in August 2017 and is headquartered in Boca Raton, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rubin Steven DDirectorMar 19 '25Sale38.9310,000389,300141,138Mar 21 06:30 PM
Rubin Steven DDirectorMar 19 '25Proposed Sale38.9310,000389,307Mar 19 04:41 PM
Stanton Lisa M.DirectorMar 07 '25Buy36.121,00036,12026,815Mar 10 04:30 PM
BENZ PETERDirectorMar 06 '25Proposed Sale37.7520,000755,000Mar 06 12:40 PM
BENZ PETERDirectorNov 26 '24Sale37.4322,300834,80080,766Nov 27 06:30 PM
XERS - Xeris Biopharma Holdings Inc - Stock Price Chart
TickerXERS [NASD, RUT]
CompanyXeris Biopharma Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap794.33MEPS (ttm)-0.38
P/E-EPS this Y82.22%
Forward P/E44.38EPS next Y276.70%
PEG-EPS past 5Y40.01%
P/S3.57EPS next 5Y-
P/B-EPS Q/Q55.22%
Dividend-Sales Q/Q47.94%
Insider Own7.80%Inst Own41.40%
Insider Trans-0.33%Inst Trans1.32%
Short Float13.42%EarningsMay 08/b
Analyst Recom1.33Target Price6.25
Avg Volume3.15M52W Range1.72 - 6.07
Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hecht BethSee RemarksMar 20 '25Sale5.4340,000217,2441,353,510Mar 21 05:31 PM
Hecht BethOfficerMar 20 '25Proposed Sale5.1440,000205,600Mar 20 05:26 PM
Pieper StevenSee RemarksNov 22 '24Option Exercise1.5519,48330,1991,441,820Nov 26 05:00 PM
Schmid John P.DirectorAug 12 '24Buy2.254,51510,14725,200Aug 13 04:15 PM
Schmid John P.DirectorAug 09 '24Buy2.374,28510,13420,685Aug 12 06:28 PM
INFU - InfuSystem Holdings Inc - Stock Price Chart
TickerINFU [AMEX, RUT]
CompanyInfuSystem Holdings Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap114.96MEPS (ttm)0.11
P/E51.12EPS this Y31.82%
Forward P/E18.54EPS next Y103.45%
PEG-EPS past 5Y10.59%
P/S0.84EPS next 5Y-
P/B2.08EPS Q/Q75.95%
Dividend-Sales Q/Q8.50%
Insider Own9.27%Inst Own69.77%
Insider Trans-2.01%Inst Trans0.31%
Short Float1.34%EarningsMay 08/b
Analyst Recom1.00Target Price13.62
Avg Volume137.84K52W Range4.61 - 9.97
InfuSystem Holdings, Inc. engages in the provision of healthcare services. It operates through the Patient Services and Device Solutions segments. The Patient Services segment involves the durable medical equipment, clinic-to-home health care, logistics and billing, and oncology business. The Device Solutions segment includes the sale or rent of new and pre-owned pole-mounted and ambulatory infusion pumps, treatment-related consumables, biomedical recertification, maintenance and repair services for oncology practices. The company was founded by Steven E. Watkins in August 2005 and headquartered in Rochester Hills, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dilorio RichardChief Executive OfficerMar 07 '25Option Exercise2.6025,00065,000441,659Mar 11 07:46 PM
Dilorio RichardChief Executive OfficerNov 25 '24Sale9.3220,000186,416436,659Nov 27 06:24 PM
Dilorio RichardChief Executive OfficerNov 26 '24Sale8.9114,602130,165422,057Nov 27 06:24 PM
Dilorio RichardChief Executive OfficerNov 27 '24Sale8.875,39847,885416,659Nov 27 06:24 PM
Richard DilorioDirectorNov 25 '24Proposed Sale9.3340,000373,200Nov 25 04:40 PM
PTIX - Protagenic Therapeutics Inc - Stock Price Chart
TickerPTIX [NASD]
CompanyProtagenic Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.06MEPS (ttm)-15.83
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-10.56%
P/S-EPS next 5Y-
P/B1.79EPS Q/Q37.57%
Dividend-Sales Q/Q-
Insider Own20.96%Inst Own4.73%
Insider Trans0.00%Inst Trans-3.72%
Short Float4.49%Earnings-
Analyst Recom-Target Price-
Avg Volume440.98K52W Range2.35 - 26.18
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
1456789101112131420